Affimed N.Vの収入
Affimed N.Vの収入 は何ですか。
Affimed N.V.の収入 は-75.65€です。
収入 の定義は何ですか。
普通株主に帰属する当期純利益は、純利益から優先配当金を差し引いた金額です。優先配当
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
NASDAQのセクタHealth Careにおける収入 の企業と比べるAffimed N.V
Affimed N.Vは何をしますか。
affimed (symbol: afmd) is a nasdaq-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. immuno-oncology represents a highly promising approach to cancer treatment that seeks to harness the body’s own immune defenses to attack and destroy tumor cells. natural killer cells, or nk-cells, and t-cells belong to the most potent cells of the human defense arsenal. affimed’s proprietary, next-generation bispecific antibodies, termed tandabs®, are designed to bring nk-cells or t-cells into close proximity to cancer cells that ultimately triggers a signal cascade that leads to the destruction of cancer cells. due to their novel tetravalent tandem architecture, which provides for four binding domains, the tandabs bind to specific targets on immune and cancer cells with high affinity. in addition, tandabs exhibit kinetic properties allowing the administration as regular intravenous infusion and fine-tuning of dosing. affimed beli
Affimed N.Vと類似の収入
- Equilliumの収入 は-75.82$です。
- U.S. Well Servicesの収入 は-75.75$です。
- Aligos Therapeuticsの収入 は-75.74$です。
- Beijing Jingkelongの収入 は-75.68¥です。
- Vaxartの収入 は-75.67$です。
- Vaxart Incの収入 は-75.66$です。
- Affimed N.Vの収入 は-75.65€です。
- Kootenay Silver Incの収入 は-75.63CAD$です。
- Prosperity Real Estate Investment Trustの収入 は-75.60HKD$です。
- MOGの収入 は-75.56¥です。
- Gokaldas Exportsの収入 は-75.56₨です。
- Northwest Biotherapeuticsの収入 は-75.55$です。
- Electreon Wireless Ltdの収入 は-75.29₪です。